|
|
Continuum,
February 2006,
Volume 12,
Issue 1
| Key Points for Issue. (pdf) |
|
faculty.
(PDF only)
|
|
editor's preface.
- Miller, Aaron
|
|
emergency management of intracerebral hemorrhage.
- Goldstein, Joshua, Greenberg, Steven, Rosand, Jonathan
>
Show/Hide Abstract
Intracerebral hemorrhage is the most devastating form of acute stroke. Hematoma growth after diagnosis is common and associated with worse outcome; therefore, early management is often considered critical. Several factors that predict poor outcome can be treated in the acute setting, including hypoxia, high blood pressure, pyrexia, hyperglycemia, edema, and seizure activity. In addition, surgical decompression can benefit selected patients, depending upon hematoma location and presence of mass effect. Early and careful management of airway, blood pressure, coagulopathy (including warfarin use), intracranial pressure, and serum glucose levels are mainstays of emergency management of intracerebral hemorrhage.(C) 2006 American Academy of Neurology
|
|
hypertensive encephalopathy, eclampsia, and reversible posterior leukoencephalopathy.
- Becker, Kyra
>
Show/Hide Abstract
Reversible posterior leukoencephalopathy is a syndrome defined by magnetic resonance imaging and is most commonly seen in patients with hypertensive encephalopathy and eclampsia. In this chapter, the diagnostic approach to these disorders and a practical approach to treatment will be reviewed.(C) 2006 American Academy of Neurology
|
|
coma in the intensive care unit: predicting awakening following cardiac and respiratory arrest.
- Tirschwell, David
>
Show/Hide Abstract
Accurately predicting the chances of awakening following cardiorespiratory arrest is important to help families make decisions about continued medical care. Falsely pessimistic predictions of never awakening (when awakening may have occurred if the patient was supported long enough) should be avoided. The vast majority (approximately 90%) of patients who will awaken do so within the first 3 days, and most patients should be supported for this duration. Absent motor response to pain or absent pupillary light reflex 3 days after cardiac arrest are strongly associated with never awakening. Early myoclonus frequently, but not uniformly, portends an ominous prognosis. Absent bilateral short-latency somatosensory evoked potentials may be the most reliable prognostic test available today, but the sensitivity for identifying patients who will not awaken runs only approximately 44%. Depending on local availability, electroencephalography and biochemical tests may provide supporting information. Imaging results, even with the use of modern magnetic resonance imaging techniques, have not been well-enough characterized in large blinded studies to be useful in predicting outcome.(C) 2006 American Academy of Neurology
|
|
status epilepticus.
- Mirski, Marek, Varelas, Panayiotis
>
Show/Hide Abstract
Status epilepticus (SE) is a term used to describe a state of unremitting seizures. It includes several clinical seizure types that have in common a prolonged duration of activity. The duration to meet the diagnosis of SE has recently been abbreviated. This is important in attempts to limit cerebral injury from prolonged SE, especially convulsive SE, which represents a true neurological emergency. The list of etiologies of SE differs between out-of-hospital and inpatient venues. Acute drug withdrawal and cerebral injury are common outpatient triggers of SE. Metabolic derangements frequent hospitalized patients with new-onset SE, and drug toxicity is an unusual but important etiology to consider of intensive care unit seizures. An electroencephalogram remains an important tool both to effectively treat SE as well as to recognize nonconvulsive SE, which is more common than currently appreciated. Early termination of SE is key to limiting cerebral pathology and patient morbidity. The emphasis on rapid control supports early consideration of critical care intervention and electroencephalogram suppression.(C) 2006 American Academy of Neurology
|
|
monitoring and managing intracranial pressure.
- Kincaid, M., Lam, Arthur
>
Show/Hide Abstract
Head injury is the most common cause of intracranial hypertension requiring intracranial pressure (ICP) monitoring, but other causes include spontaneous intracranial hemorrhage, tumors, stroke, and infection. In head injury, ICP monitoring is indicated in any patient with a Glasgow Coma Score less than 8 at admission and an abnormal computed tomographic scan of the head or two of the following: motor posturing, age greater than 40, or systemic hypotension. Goals for management include ICP less than 20 mm Hg and cerebral perfusion pressure between 60 mm Hg and 70 mm Hg. Mass lesions, including tumors and hematomas, warrant surgical intervention. For other causes of intracranial hypertension, head-up position, mannitol, hypertonic saline, and barbiturates are possible therapeutic options. Moderate hypothermia is an additional option, as is hyperventilation, although these latter therapies entail additional unique risks. Finally, decompressive craniectomy remains a controversial intervention for refractory intracranial hypertension.(C) 2006 American Academy of Neurology
|
|
index.
(PDF only)
|
|
multiple-choice questions.
- Gelb, Douglas, Lynn, D.
|
|
patient management problem.
- Sung, Gene
|
|
preferred responses.
- Gelb, Douglas, Lynn, D.
|
|
list of abbreviations.
|
The AAN is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical
education (CME) for physicians.
The AAN designates this educational activity for a maximum of 10 American Medical Association (AMA) Physician Recognition Award
(PRA) Category 1 Credits™. Physicians should claim only those hours of credit that they actually spend in the educational activity.
Per AMA PRA guidelines, only US and licensed international physicians may be awarded AMA PRA Category 1 Credit certificates. The
AAN will issue certificates of participation to non-MD/DO health professionals indicating that the activity was designated
for AMA PRA Category 1 Credit.
The American Board of Psychiatry and Neurology has reviewed
Continuum: Lifelong Learning in Neurology® and has approved the product as part of a
comprehensive lifelong learning program, which is mandated by the American Board of Medical Specialties
as a necessary component of maintenance of certification.
Andrea Weiss
Associate Publisher, AAN Enterprises, Inc.
Managing Editor, Continuum and Quintessentials
aweiss@aan.com
(651) 695-2742
|
|